|
|
|
Dec, 27 |
|
Lupin and Cornerstone End Development Agreement |
|
|
|
Dec, 25 |
|
Lupin's US Subsidiary and Chester Valley Pharmaceuticals decide to end promotion agreement |
|
|
|
Dec, 19 |
|
Lupin gets tentative US FDA approval for Trandolapril |
|
|
|
Dec, 7 |
|
Lupin gets DCGI approval to conduct Phase III clinical trials for Migraine NCE |
|
|
|
Oct, 19 |
|
Lupin FY 2006-07 Q2 Net Profit up by 29% at Rs.583 mn |
|
Mr. Edward R. Roberts joins Lupin Board |
|
|
|
Sept, 30 |
|
Lupin and Dafra decide not to pursue their MoU |
|
|
|
Sept, 28 |
|
Lupin gets US FDA approval for Lisinopril-HCTZ Tablets |
|
|
|
Sept, 14 |
|
Lupin gets US FDA approval for Ceftriaxone 10gm vials |
|
|
|
July, 26 |
|
Lupin receives DCGI approval to conduct Phase II Clinical Trials for Psoriasis NCE |
|
|
|
July, 25 |
|
Lupin FY 2006-07 Q1 Sales up by 33% at Rs.4.9 bn |
|
|
|
July, 20 |
|
Lupin gets USFDA approval for Meloxicam |
|
|
|
July, 19 |
|
Lupin announces District Court Ruling on Ramipril |
|
|
|
June, 23 |
|
Lupin Receives final approval for Quinapril Tablets |
|
|
|
June, 19 |
|
Rajan Dutta joins Lupin as President, HRD |
|
|
|
June, 2 |
|
Lupin gets USFDA approval for Cefdinir Suspension |
|
|
|
May, 25 |
|
Lupin to acquire 51% stake in Dafra |
|
|
|
May, 23 |
|
Lupin Announces Final FDA Approval of Cefdinir Capsules |
|
|
|
May, 15 |
|
Lupin joins hands with ItalFarmaco to launch Lupenox in India |
|
|
|
April, 27 |
|
DST and Lupin join hands over Migraine and Psoriasis |
|
|
|
April, 12 |
|
Lupin receives US FDA Approval for Novel Formulation of Suprax® Suspension |
|
|
|
April, 5 |
|
Lupin finalizes patent sale agreement with Servier |
|
|
|
March, 13 |
|
Lupin gets Marketing Approval for Cefpodoxime Proxetil in France |
|
|
|
March, 3 |
|
Lupin’s US Subsidiary Enters Into Collaboration to Promote Atopiclair™ Nonsteroidal Cream to Pediatricians in the U.S |
|
|
|
Feb, 27 |
|
Lupin-Aspen sign
Joint Venture |
|
Lupin LCTL Divestment |
|
|
|
Feb, 21 |
|
Lupin to Reorganise Sale Structure for Suprax |
|
|
|
Feb, 20 |
|
Lupin sells Intellectual Property on Perindopril to Servier |
|
|
|
Feb, 7 |
|
Lupin receives US FDA approval for Sertraline |
|
|
|
Jan, 19 |
|
Lupin and Aspen decide not to pursue their MOU |
|
|
|
Jan, 17 |
|
Lupin FY 2006-07 Q3 Net Profit up by 27% at Rs.560 mn |
|
|
|
Jan, 2 |
|
Lupin gets tentative
US FDA approval for Sertraline |
